Hypertrophic cardiomyopathy screening

Hypertrophic cardiomyopathy, HCM can be symptomatic or asymptomatic. In a limited number of cases it can lead to sudden cardiac death, SCD. Screening is sometimes used with the aim of reducing SCD.

Main article: Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy screening
Purposedetect and prevent sudden cardiac death

Description

HCM is a genetic disorder that causes the muscle of the heart (the myocardium) to thicken (or hypertrophy). It can cause dangerous arrhythmias (abnormal heart rhythms). The thickening of the heart also makes it harder for blood to leave, forcing the heart to work more vigorously to pump blood.

HCM occurs in approximately 2 per 1,000 people in the general population, being a primary and familial malformation. The condition is seen in people of all ages. Some studies indicate that HCM is a cause of sudden cardiac death in athletes. The disease is equally prevalent in males and females.

Screening and diagnosis

Screening to detect HCM is an important process in preventing a possible sudden cardiac death.

gollark: βεστ ος
gollark: ποτατος
gollark: Ρ!
gollark: υεσ
gollark: ω βασε ις βαδ.

References
    • Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians by Barry J. Maron), Lisa Salberg - 3rd Edition
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.